396 related articles for article (PubMed ID: 28778717)
21. Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
Böttcher-Friebertshäuser E; Lu Y; Meyer D; Sielaff F; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2012 Dec; 30(51):7374-80. PubMed ID: 23072892
[TBL] [Abstract][Full Text] [Related]
22. Development of Small-Molecule MERS-CoV Inhibitors.
Liang R; Wang L; Zhang N; Deng X; Su M; Su Y; Hu L; He C; Ying T; Jiang S; Yu F
Viruses; 2018 Dec; 10(12):. PubMed ID: 30562987
[TBL] [Abstract][Full Text] [Related]
23. Recent discoveries of influenza A drug target sites to combat virus replication.
Patel H; Kukol A
Biochem Soc Trans; 2016 Jun; 44(3):932-6. PubMed ID: 27284062
[TBL] [Abstract][Full Text] [Related]
24. Health experts consider pandemic risks of influenza viruses, coronaviruses.
Cima G
J Am Vet Med Assoc; 2014 May; 244(10):1102-4. PubMed ID: 24908695
[No Abstract] [Full Text] [Related]
25. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
Front Immunol; 2019; 10():60. PubMed ID: 30761132
[TBL] [Abstract][Full Text] [Related]
26. Chemical Genomics Identifies the PERK-Mediated Unfolded Protein Stress Response as a Cellular Target for Influenza Virus Inhibition.
Landeras-Bueno S; Fernández Y; Falcón A; Oliveros JC; Ortín J
mBio; 2016 Apr; 7(2):e00085-16. PubMed ID: 27094326
[TBL] [Abstract][Full Text] [Related]
27. [Development of Targets for Anti-influenza Virus Based on Nucleoprotein].
Huang Z; Sun J
Bing Du Xue Bao; 2015 Jul; 31(4):450-6. PubMed ID: 26524919
[TBL] [Abstract][Full Text] [Related]
28. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses.
Beppu Y; Imamura Y; Tashiro M; Towatari T; Ariga H; Kido H
J Biochem; 1997 Feb; 121(2):309-16. PubMed ID: 9089405
[TBL] [Abstract][Full Text] [Related]
29. Iminosugars: Promising therapeutics for influenza infection.
Tyrrell BE; Sayce AC; Warfield KL; Miller JL; Zitzmann N
Crit Rev Microbiol; 2017 Sep; 43(5):521-545. PubMed ID: 27931136
[TBL] [Abstract][Full Text] [Related]
30. [Aprotinin-induced inhibition of pandemic influenza virus A(H1N1) reproduction].
Zhirnov OP; Klenk HD
Vopr Virusol; 2011; 56(3):24-8. PubMed ID: 21786623
[TBL] [Abstract][Full Text] [Related]
31. Coronavirus: hospitals must learn from past pandemics.
Bhadelia N
Nature; 2020 Feb; 578(7794):193. PubMed ID: 32047315
[No Abstract] [Full Text] [Related]
32. Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.
Hayashi H; Kubo Y; Izumida M; Takahashi E; Kido H; Sato K; Yamaya M; Nishimura H; Nakayama K; Matsuyama T
Front Cell Infect Microbiol; 2018; 8():91. PubMed ID: 29629340
[TBL] [Abstract][Full Text] [Related]
33. Recent progress in the discovery of inhibitors targeting coronavirus proteases.
Wang H; Xue S; Yang H; Chen C
Virol Sin; 2016 Feb; 31(1):24-30. PubMed ID: 26920707
[TBL] [Abstract][Full Text] [Related]
34. Ceramide Suppresses Influenza A Virus Replication
Soudani N; Hage-Sleiman R; Karam W; Dbaibo G; Zaraket H
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700605
[TBL] [Abstract][Full Text] [Related]
35. De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.
Wang C; Zhao L; Xia S; Zhang T; Cao R; Liang G; Li Y; Meng G; Wang W; Shi W; Zhong W; Jiang S; Liu K
J Med Chem; 2018 Oct; 61(19):8734-8745. PubMed ID: 30192544
[TBL] [Abstract][Full Text] [Related]
36. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
37. Perspective of Use of Antiviral Peptides against Influenza Virus.
Skalickova S; Heger Z; Krejcova L; Pekarik V; Bastl K; Janda J; Kostolansky F; Vareckova E; Zitka O; Adam V; Kizek R
Viruses; 2015 Oct; 7(10):5428-42. PubMed ID: 26492266
[TBL] [Abstract][Full Text] [Related]
38. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus.
Rossignol JF
J Infect Public Health; 2016; 9(3):227-30. PubMed ID: 27095301
[TBL] [Abstract][Full Text] [Related]
39. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
Böttcher E; Matrosovich T; Beyerle M; Klenk HD; Garten W; Matrosovich M
J Virol; 2006 Oct; 80(19):9896-8. PubMed ID: 16973594
[TBL] [Abstract][Full Text] [Related]
40. Drug targets for rational design against emerging coronaviruses.
Zhao Q; Weber E; Yang H
Infect Disord Drug Targets; 2013 Apr; 13(2):116-27. PubMed ID: 23895136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
